COVID-19 Vaccines from Pfizer/BioNTech and Moderna
The three products whose trials were halted are not vaccines but, rather, antibodies that treat patients who already have COVID-19. With regard to the COVID-19 vaccines we believe we have encouraging news from Pfizer/BioNTech’s and Moderna’s mRNA vaccines.
The Pfizer/BioNTech Vaccine
Pfizer (PFE) Chairman and CEO, Albert Bourla, stated that the mRNA vaccine developed together with BioNTech (BNTX) will be ready for Emergency Use Authorization by late November 2020. Pfizer and BioNTech announced they are scaling up the manufacturing capacity of the vaccine. The firms seem to be able to deliver the doses they promised governments around the world to deliver.